A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants
Phase 1 Withdrawn
An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer
Phase 1 Withdrawn
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Withdrawn
A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations
Phase 1 Withdrawn
Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors
Phase 1 Withdrawn
Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Phase 1 Withdrawn
Investigation of Cannabis for Pain and Inflammation in Lung Cancer
Phase 1 Withdrawn
NSCLC
Phase 1 Withdrawn
Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors
Phase 1 Withdrawn
Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer
Phase 1 Withdrawn
Intraoperative Imaging of Pulmonary Adenocarcinoma
Phase 1 Withdrawn
S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
Phase 1 Withdrawn
Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery
Phase 1 Withdrawn
Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)
Phase 1 Withdrawn
Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1 Withdrawn
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
Phase 1 Withdrawn
A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer
Phase 1 Withdrawn
Celecoxib Treatment for Lung Cancer
Phase 1 Withdrawn
Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer
Phase 1 Withdrawn
Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer
Phase 1 Withdrawn
Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases
Phase 1 Withdrawn
Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)
Phase 1 Withdrawn
KRN7000 in Treating Patients With Solid Tumors
Phase 1 Withdrawn